These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37457471)

  • 21. Synthesis, Docking Studies, and In Vitro Evaluation of Some Novel Thienopyridines and Fused Thienopyridine-Quinolines as Antibacterial Agents and DNA Gyrase Inhibitors.
    Mohi El-Deen EM; Abd El-Meguid EA; Hasabelnaby S; Karam EA; Nossier ES
    Molecules; 2019 Oct; 24(20):. PubMed ID: 31658631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery of Benzothiazole Scaffold-Based DNA Gyrase B Inhibitors.
    Gjorgjieva M; Tomašič T; Barančokova M; Katsamakas S; Ilaš J; Tammela P; Peterlin Mašič L; Kikelj D
    J Med Chem; 2016 Oct; 59(19):8941-8954. PubMed ID: 27541007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, synthesis, and antibacterial evaluation of new quinoline-1,3,4-oxadiazole and quinoline-1,2,4-triazole hybrids as potential inhibitors of DNA gyrase and topoisomerase IV.
    Hofny HA; Mohamed MFA; Gomaa HAM; Abdel-Aziz SA; Youssif BGM; El-Koussi NA; Aboraia AS
    Bioorg Chem; 2021 Jul; 112():104920. PubMed ID: 33910078
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hybrid Inhibitors of DNA Gyrase A and B: Design, Synthesis and Evaluation.
    Durcik M; Skok Ž; Ilaš J; Zidar N; Zega A; Szili PÉ; Draskovits G; Révész T; Kikelj D; Nyerges A; Pál C; Mašič LP; Tomašič T
    Pharmaceutics; 2020 Dec; 13(1):. PubMed ID: 33374964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. N-Phenyl-4,5-dibromopyrrolamides and N-Phenylindolamides as ATP Competitive DNA Gyrase B Inhibitors: Design, Synthesis, and Evaluation.
    Zidar N; Macut H; Tomašič T; Brvar M; Montalvão S; Tammela P; Solmajer T; Peterlin Mašič L; Ilaš J; Kikelj D
    J Med Chem; 2015 Aug; 58(15):6179-94. PubMed ID: 26126187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Repositioning of Benzodiazepine Drugs and Synergistic Effect with Ciprofloxacin Against ESKAPE Pathogens.
    da Rosa TF; Serafin MB; Foletto VS; Franco LN; de Paula BR; Fuchs LB; Calegari L; Hörner R
    Curr Microbiol; 2023 Apr; 80(5):160. PubMed ID: 37004588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Benzothiazole-Phthalimide Hybrids as Anti-Breast Cancer and Antimicrobial Agents.
    Barbarossa A; Ceramella J; Carocci A; Iacopetta D; Rosato A; Limongelli F; Carrieri A; Bonofiglio D; Sinicropi MS
    Antibiotics (Basel); 2023 Nov; 12(12):. PubMed ID: 38136685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pyrrolopyrimidine inhibitors of DNA gyrase B (GyrB) and topoisomerase IV (ParE), Part II: development of inhibitors with broad spectrum, Gram-negative antibacterial activity.
    Trzoss M; Bensen DC; Li X; Chen Z; Lam T; Zhang J; Creighton CJ; Cunningham ML; Kwan B; Stidham M; Nelson K; Brown-Driver V; Castellano A; Shaw KJ; Lightstone FC; Wong SE; Nguyen TB; Finn J; Tari LW
    Bioorg Med Chem Lett; 2013 Mar; 23(5):1537-43. PubMed ID: 23294697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery of New Schiff Bases Tethered Pyrazole Moiety: Design, Synthesis, Biological Evaluation, and Molecular Docking Study as Dual Targeting DHFR/DNA Gyrase Inhibitors with Immunomodulatory Activity.
    Hassan AS; Askar AA; Naglah AM; Almehizia AA; Ragab A
    Molecules; 2020 Jun; 25(11):. PubMed ID: 32498469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of novel multi-substituted benzo-indole pyrazole schiff base derivatives with antibacterial activity targeting DNA gyrase.
    Liu H; Chu ZW; Xia DG; Cao HQ; Lv XH
    Bioorg Chem; 2020 Jun; 99():103807. PubMed ID: 32272364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New Broad-Spectrum Antibiotics Containing a Pyrrolobenzodiazepine Ring with Activity against Multidrug-Resistant Gram-Negative Bacteria.
    Picconi P; Hind CK; Nahar KS; Jamshidi S; Di Maggio L; Saeed N; Evans B; Solomons J; Wand ME; Sutton JM; Rahman KM
    J Med Chem; 2020 Jul; 63(13):6941-6958. PubMed ID: 32515951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New N-phenylpyrrolamide DNA gyrase B inhibitors: Optimization of efficacy and antibacterial activity.
    Durcik M; Lovison D; Skok Ž; Durante Cruz C; Tammela P; Tomašič T; Benedetto Tiz D; Draskovits G; Nyerges Á; Pál C; Ilaš J; Peterlin Mašič L; Kikelj D; Zidar N
    Eur J Med Chem; 2018 Jun; 154():117-132. PubMed ID: 29778894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and Biological Evaluation of New Pyridothienopyrimidine Derivatives as Antibacterial Agents and
    Mohi El-Deen EM; Abd El-Meguid EA; Karam EA; Nossier ES; Ahmed MF
    Antibiotics (Basel); 2020 Oct; 9(10):. PubMed ID: 33066400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design, Synthesis, and Antibacterial Screening of Some Novel Heteroaryl-Based Ciprofloxacin Derivatives as DNA Gyrase and Topoisomerase IV Inhibitors.
    Al-Wahaibi LH; Amer AA; Marzouk AA; Gomaa HAM; Youssif BGM; Abdelhamid AA
    Pharmaceuticals (Basel); 2021 Apr; 14(5):. PubMed ID: 33922361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C8-Linked Pyrrolobenzodiazepine Monomers with Inverted Building Blocks Show Selective Activity against Multidrug Resistant Gram-Positive Bacteria.
    Andriollo P; Hind CK; Picconi P; Nahar KS; Jamshidi S; Varsha A; Clifford M; Sutton JM; Rahman KM
    ACS Infect Dis; 2018 Feb; 4(2):158-174. PubMed ID: 29260545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distribution and Carbapenem Susceptibility of Gram-Negative ESKAPE Pathogens in Hospitalized Patients from Three General Hospitals.
    Zhong S; He S
    Clin Lab; 2021 Feb; 67(2):. PubMed ID: 33616331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, synthesis and biological evaluation of novel Pseudomonas aeruginosa DNA gyrase B inhibitors.
    Jogula S; Krishna VS; Meda N; Balraju V; Sriram D
    Bioorg Chem; 2020 Jul; 100():103905. PubMed ID: 32388436
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Computational Insight into the Mechanism of Action of DNA Gyrase Inhibitors; Revealing a New Mechanism.
    Muhammed MT; Aki-Yalcin E
    Curr Comput Aided Drug Des; 2024; 20(3):224-235. PubMed ID: 37114781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hydroxy tricyclic 1,5-naphthyridinone oxabicyclooctane-linked novel bacterial topoisomerase inhibitors as broad-spectrum antibacterial agents-SAR of RHS moiety (Part-3).
    Singh SB; Kaelin DE; Wu J; Miesel L; Tan CM; Gill C; Black T; Nargund R; Meinke PT; Olsen DB; Lagrutta A; Wei C; Peng X; Wang X; Fukuda H; Kishii R; Takei M; Takeuchi T; Shibue T; Ohata K; Takano H; Ban S; Nishimura A; Fukuda Y
    Bioorg Med Chem Lett; 2015 Jun; 25(12):2473-8. PubMed ID: 25978963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An optimised series of substituted N-phenylpyrrolamides as DNA gyrase B inhibitors.
    Tiz DB; Skok Ž; Durcik M; Tomašič T; Mašič LP; Ilaš J; Zega A; Draskovits G; Révész T; Nyerges Á; Pál C; Cruz CD; Tammela P; Žigon D; Kikelj D; Zidar N
    Eur J Med Chem; 2019 Apr; 167():269-290. PubMed ID: 30776691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.